Clinical TrialsSearch results
Number of results: 482
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy in treating pediatric patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumors
- medulloblastoma or supratentorial primitive neuroectodermal tumors
- Japanese Pediatric Brain Tumor Consortium
- 2006-12-08
Other
- Phase II study of neoadjuvant treatment with Exemestane for 24 weeks in postmenopausal women with hormone receptor positive Stage II or IIIA breast cancer.
- Breast Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-03-06
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Phase II study of irinotecan and amrubicin for relapsed non-small-cell lung cancer
- Relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of imatinib mesylate for treatment of Philadelphia Chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in children: A Japanese Cooperative Trial
- Philadelphia Chromosome-positive acute lymphoblastic leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2005-12-01
Other
- phase II study of gefitinib as a first-line therapy in elderly patients with lung adenocarcinoma.
- lung adenocarcinoma
- West Japan Oncology Group
- 2005-09-08
Other
- Phase II study of erlotinib monotherapy for relapsed patients with non-small-cell lung cancer who do not possess any active EGFR gene mutations
- relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2008-11-16
Other
- phase II study of Erlotinib for non-small cell lung cancer patients with EGFR mutation
- non-small cell lung cancer
- Nagasaki Thoracic Oncology Group
- 2009-04-04